HISTOGENICS CORP Contracts & Agreements

Underwriting Agreement, dated July 31, 2024, by and between Ocugen, Inc. and Titan Partners Group LLC, a division of American Capital Partners, LLC (Filed With SEC on August 1, 2024)

Executive Employment Agreement, dated as of March 18, 2024, by and between the Registrant and Huma Qamar (Filed With SEC on May 14, 2024)

Third Amendment to the Co-Development and Commercialization Agreement, dated April 11, 2023, by and between the Registrant (Filed With SEC on April 16, 2024)

Second Amendment to the Exclusive License Agreement by and between the Registrant and The Washington University, dated as of November 28, 2023 (Filed With SEC on April 16, 2024)

Form of Performance Restricted Stock Unit Award Agreement (Filed With SEC on January 8, 2024)

Underwriting Agreement, dated May 24, 2023, by and between Ocugen, Inc. and Cantor Fitzgerald & Co (Filed With SEC on May 25, 2023)

Executive Employment Agreement, dated as of January 13, 2023, by and between the Registrant and Quan Vu (Filed With SEC on May 5, 2023)

Form of Incentive Stock Option Agreement under Ocugen, Inc. 2019 Equity Incentive Plan (Filed With SEC on February 28, 2023)

Form of Non (Filed With SEC on February 28, 2023)

Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (Filed With SEC on February 28, 2023)

Form of Non-Qualified Stock Option Agreement for Inducement Non-Qualified Stock Option Awards (Filed With SEC on February 28, 2023)

Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement for Inducement Restricted Stock Unit Awards (Filed With SEC on February 28, 2023)

Second Amendment to the Co-Development and Commercialization Agreement, dated November 21, 2022, by and between the Registrant and CanSino Biologics, Inc (Filed With SEC on February 28, 2023)

First Amendment to the (Filed With SEC on February 28, 2023)

Amended and Restated Executive Employment Agreement, dated as of December 16, 2021, by and between the Registrant and Arun Upadhyay (Filed With SEC on February 28, 2023)

First Amendment to Amended and Restated Executive Employment Agreement, dated as of August 26, 2022, by and between the Registrant and Arun Upadhyay (Filed With SEC on February 28, 2023)

Exclusive License Agreement by and between Ocugen, Inc. and The Washington University, dated as of September 23, 2022 (Filed With SEC on November 8, 2022)

At Market Issuance Sales Agreement, dated June 10, 2022, by and among Ocugen, Inc., Cantor Fitzgerald & Co., Mizuho Securities USA LLC, H.C. Wainwright & Co., LLC, Roth Capital... (Filed With SEC on June 10, 2022)

Second Amendment to Co-Development, Supply and Commercialization Agreement, dated as of April 15, 2022, by and between the Registrant and Bharat Biotech International Limited (Filed With SEC on May 6, 2022)

Amended and Restated Employment Agreement, dated as of March 18, 2022, by and between the Registrant and Jessica Crespo (Filed With SEC on May 6, 2022)

First Amendment to Amended and Restated Executive Employment Agreement, dated as of April 27, 2022, by and between the Registrant and Shankar Musunuri (Filed With SEC on May 6, 2022)

Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 28, 2022)

Form of Common Stock Purchase Warrant with Liminal (Filed With SEC on February 28, 2022)

Underwriting Agreement, dated February 22, 2022, by and between Ocugen, Inc. and Cantor Fitzgerald & Co (Filed With SEC on February 25, 2022)

Development and Commercial Supply Agreement, dated September 29, 2021, by and between the Registrant and Bharat Biotech International Limited (Filed With SEC on November 9, 2021)

First Amendment to (Filed With SEC on November 9, 2021)

First Amendment to Co-Development, Supply and Commercialization Agreement, dated as of May 29, 2021, by and between the Registrant and Bharat Biotech International Limited (Filed With SEC on August 6, 2021)

Form of Stock Option Agreement for Inducement Option Awards (Filed With SEC on August 6, 2021)

Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement for Inducement Restricted Stock Unit Awards (Filed With SEC on August 6, 2021)

Co-Development, Supply and Commercialization Agreement, dated as of January 31, 2021, by and between the Registrant and Bharat Biotech International Limited (Filed With SEC on May 7, 2021)

Form of Performance-Vested Stock Option Agreement under Ocugen, Inc. 2019 Equity Incentive Plan (Filed With SEC on May 7, 2021)

Form of Securities Purchase Agreement (Filed With SEC on April 27, 2021)

Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 19, 2021)

Form of Common Stock Purchase Warrant (Filed With SEC on March 19, 2021)

Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (Filed With SEC on March 19, 2021)

Lease Agreement, dated October 9, 2020, by and between the Registrant and WPT Land 2 LP (Filed With SEC on March 19, 2021)

Form of Securities Purchase Agreement (Filed With SEC on February 9, 2021)

At Market Issuance Sales Agreement, dated August 14, 2020, by and among Ocugen, Inc., Cantor Fitzgerald & Co. and Oppenheimer & Co. Inc (Filed With SEC on August 17, 2020)

Controlled Equity OfferingSM Sales Agreement, dated June 12, 2020, by and between Ocugen, Inc. and Cantor Fitzgerald & Co (Filed With SEC on June 12, 2020)

Amended and Restated Employment Agreement, dated as of January 1, 2020, by and between the Registrant and Vijay Tam (Filed With SEC on May 8, 2020)

Amended and Restated Employment Agreement, dated as of January 1, 2020, by and between the Registrant and Kelly Beck (Filed With SEC on May 8, 2020)

Amendment to Executive Employment Agreement, dated as of January 1, 2020, by and between Registrant and Sanjay Subramanian (Filed With SEC on May 8, 2020)

Controlled Equity OfferingSM Sales Agreement, dated May 8, 2020, by and between Ocugen, Inc. and Cantor Fitzgerald & Co (Filed With SEC on May 8, 2020)

Note dated April 30, 2020, between Ocugen, Inc. and Silicon Valley Bank (Filed With SEC on May 1, 2020)

Form of Amendment and Exchange Agreement dated as of April 22, 2020, by and between Ocugen, Inc., Ocugen Opco, Inc. and the Investor named therein (Filed With SEC on April 22, 2020)

Form of Promissory Note dated April 22, 2020, issued by Ocugen Inc (Filed With SEC on April 22, 2020)

Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 27, 2020)

Form of In (Filed With SEC on March 27, 2020)

Form of Nonstatutory Stock Option Agreement under Ocugen, Inc. 2019 Equity Incentive Plan (Filed With SEC on March 27, 2020)

Amended and Restated Employment Agreement, dated January 1, 2020, by and between Ocugen, Inc. and Shankar Musunuri (Filed With SEC on January 3, 2020)

Amended and Restated Employment Agreement, dated January 1, 2020, by and between Ocugen, Inc. and Daniel Jorgensen (Filed With SEC on January 3, 2020)

Amended and Restated Employment Agreement, dated January 1, 2020, by and between Ocugen, Inc. and Rasappa Arumugham (Filed With SEC on January 3, 2020)

Co-Development and Commercialization Agreement, dated as of September 27, 2019, by and among the Registrant and CanSino Biologics Inc (Filed With SEC on November 12, 2019)

Employment Agreement, dated as of September 10, 2019, by and between the Registrant and Sanjay Subramanian (Filed With SEC on November 12, 2019)

Form of Amendment to Warrants to Purchase Common Stock (Filed With SEC on November 6, 2019)

Form of Series A Investor Warrant (Filed With SEC on October 7, 2019)

Form of Series B Investor Warrant (Filed With SEC on October 7, 2019)

Form of Series C Investor Warrant (Filed With SEC on October 7, 2019)

Amendment No. 2 to Asset Purchase Agreement, dated October 4, 2019, by and between the Company and Medavate Corp (Filed With SEC on October 7, 2019)

Amendment No. 1 to Asset Purchase Agreement, dated September 26, 2019, by and between the Company and Medavate Corp (Filed With SEC on October 1, 2019)

Form of Amendment to Securities Purchase Agreement, dated as of June 28, 2019, by and among Histogenics Corporation, Ocugen, Inc. and the investor named therein (Filed With SEC on July 3, 2019)

Consent and Amendment No. 1 to Agreement and Plan of Merger, dated June 13, 2019, by and among Histogenics Corporation, Restore Merger Sub, Inc. and Ocugen, Inc (Filed With SEC on June 14, 2019)

Form of Series A/B Warrants (Filed With SEC on June 14, 2019)

Form of Series C Warrant (Filed With SEC on June 14, 2019)

Registration Rights Agreement, dated as of June 13, 2019, by and among Histogenics Corporation and certain investors named therein (Filed With SEC on June 14, 2019)

Securities Purchase Agreement, dated as of June 13, 2019, by and among Histogenics Corporation, Ocugen, Inc. and certain investors named therein (Filed With SEC on June 14, 2019)

Form of Lock-Up Agreement (Filed With SEC on June 14, 2019)

Ocugen, Inc. 2014 Stock Option Plan (Filed With SEC on June 14, 2019)

Form of Incentive Stock Option Agreement under Ocugen, Inc. 2014 Stock Option Plan (Filed With SEC on June 14, 2019)

Form of Nonstatutory Stock Option Agreement under Ocugen, Inc. 2014 Stock Option Plan (Filed With SEC on June 14, 2019)

Exclusive License Agreement, effective as of March 3, 2014, between The Regents of the University of Colorado and Ocugen, Inc (Filed With SEC on June 14, 2019)

First Amendment to the Exclusive License Agreement, dated as of January 3, 2017, by and between The Regents of the University of Colorado and Ocugen, Inc (Filed With SEC on June 14, 2019)

Letter of Understanding, dated November 8, 2017, between The Regents of the University of Colorado and Ocugen, Inc (Filed With SEC on June 14, 2019)

Exclusive License Agreement, effective as of February 3, 2016, between The Board of Trustees of the University of Illinois and Ocugen, Inc (Filed With SEC on June 14, 2019)

Exclusive License Agreement, effective as of December 19, 2017, between The Schepens Eye Research Institute, Inc and Ocugen, Inc (Filed With SEC on June 14, 2019)

Lease Agreement, dated December 19, 2016, by and between Ocugen, Inc. and WPT Land 2 LP (Filed With SEC on June 14, 2019)

First Amendment to Lease Agreement, dated November 27, 2017, by and between the Registrant and WPT Land 2 LP (Filed With SEC on June 14, 2019)

Second Amendment to Lease Agreement, dated November 16, 2018, by and between Ocugen, Inc. and WPT Land 2 LP (Filed With SEC on June 14, 2019)

Executive Employment Agreement, dated as of January 1, 2018, by and between Ocugen, Inc. and Shankar Musunuri (Filed With SEC on June 14, 2019)

Executive Employment Agreement, dated as of April 3, 2016, by and between Ocugen, Inc. and Daniel Jorgensen (Filed With SEC on June 14, 2019)

Executive Employment Agreement, dated December 21, 2016, by and between Ocugen, Inc. and Rasappa Arumugham (Filed With SEC on June 14, 2019)

Amendment to Employment Agreement, dated March 1, 2018, by and between Ocugen, Inc. and Rasappa Arumugham (Filed With SEC on June 14, 2019)

Securities Purchase Agreement, dated as of May 21, 2019, by and among Ocugen, Inc. and the investors party thereto (Filed With SEC on June 14, 2019)

Form of Senior Secured Convertible Note, dated as of May 21, 2019, by Ocugen, Inc. to each of the investors party to the Securities Purchase Agreement, dated as of May 21, 2019 (Filed With SEC on June 14, 2019)

Security Agreement, dated as of May 21, 2019, by Ocugen, Inc. in favor of HB Fund LLC, in its capacity as collateral agent for the investors party to the Securities Purchase... (Filed With SEC on June 14, 2019)

Separation Agreement dated January 23, 2019 between the Registrant and Donald Haut, Ph.D (Filed With SEC on May 15, 2019)

Separation Agreement dated January 23, 2019 between the Registrant and Lynne Kelley, M.D., FACs (Filed With SEC on May 15, 2019)

Separation Agreement dated March 18, 2019 between the Registrant and Adam Gridley (Filed With SEC on May 15, 2019)

Separation Agreement dated March 19, 2019 between the Registrant and Stephen Kennedy (Filed With SEC on May 15, 2019)

Asset Purchase Agreement dated May 8, 2019 by and between Histogenics Corporation and Medavate Corp (Filed With SEC on May 13, 2019)

Form of Histogenics Voting Agreement, dated April 5, 2019, by and between Ocugen, Histogenics and each of the parties named in each agreement therein (Filed With SEC on April 8, 2019)

Form of Ocugen Voting Agreement, dated April 5, 2019, by and between Histogenics, Ocugen and each of the parties named in each agreement therein (Filed With SEC on April 8, 2019)

Form of Lock-Up Agreement, dated April 5, 2019, by each of the parties named in each agreement therein (Filed With SEC on April 8, 2019)

Agreement and Plan of Merger and Reorganization by and among Histogenics Corporation, Ocugen, Inc. and Restore Merger Sub, Inc., dated April 5, 2019 (Filed With SEC on April 8, 2019)

Form of 2016 Warrant Amendment and Exercise Agreement (Filed With SEC on February 8, 2019)

Form of 2018 Warrant Exercise Agreement (Filed With SEC on February 8, 2019)

Mutual Termination and Release Agreement dated December 21, 2018, between Histogenics Corporation and Intrexon Corporation (Filed With SEC on December 21, 2018)

Consulting Agreement, effective December 21, 2018, between the Company and Danforth Advisors, LLC (Filed With SEC on December 21, 2018)

Underwriting Agreement, dated October 5, 2018, by and between the Company and Canaccord Genuity LLC (Filed With SEC on October 5, 2018)

Form of Warrant (Filed With SEC on October 5, 2018)

Histogenics Corporation Executive Officer Retention Bonus Plan (Filed With SEC on October 2, 2018)

License and Commercialization Agreement dated as of December 21, 2017 between the Company and MEDINET Co., Ltd (Filed With SEC on March 15, 2018)

Equity Distribution Agreement, dated as of March 15, 2018, by and between Histogenics Corporation and Canaccord Genuity, Inc (Filed With SEC on March 15, 2018)

Underwriting Agreement between Histogenics Corporation and Canaccord Genuity Inc., dated January 22, 2018 (Filed With SEC on January 23, 2018)

Amended and Restated Employment Agreement by and between Histogenics Corporation and Stephen Kennedy dated October 10, 2017 (Filed With SEC on October 12, 2017)

SECOND AMENDMENT TO LEASE (Filed With SEC on August 10, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2017)

COMMON STOCK PURCHASE WARRANT HISTOGENICS CORPORATION (Filed With SEC on September 29, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 29, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 16, 2016)

FIRST AMENDMENT TO AGREEMENT (Filed With SEC on August 11, 2016)

HISTOGENICS CORPORATION 2013 EQUITY INCENTIVE PLAN (AS ADOPTED ON NOVEMBER 13, 2013) HISTOGENICS CORPORATION 2013 EQUITY INCENTIVE PLAN (Filed With SEC on May 4, 2016)

HISTOGENICS CORPORATION 2013 EMPLOYEE STOCK PURCHASE PLAN (AS ADOPTED ON NOVEMBER 13, 2013) HISTOGENICS CORPORATION 2013 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on May 4, 2016)

HISTOGENICS CORPORATION AMENDED AND RESTATED COMPENSATION PROGRAM FORNON-EMPLOYEE DIRECTORS EFFECTIVE AS OF JUNE 24, 2015 (Filed With SEC on March 10, 2016)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on July 30, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on June 22, 2015)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on May 14, 2015)

CONSULTING AGREEMENT (Filed With SEC on May 14, 2015)

HISTOGENICS CORPORATION 830 Winter Street Waltham, MA 02451 January 30, 2015 (Filed With SEC on February 27, 2015)

HISTOGENICS CORPORATION 2013 EQUITY INCENTIVE PLAN (AS ADOPTED ON NOVEMBER 13, 2013) HISTOGENICS CORPORATION 2013 EQUITY INCENTIVE PLAN (Filed With SEC on November 14, 2014)

HISTOGENICS CORPORATION 2013 EMPLOYEE STOCK PURCHASE PLAN (AS ADOPTED ON NOVEMBER 13, 2013) HISTOGENICS CORPORATION 2013 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on November 14, 2014)

[] Shares1 Histogenics Corporation Common Stock PURCHASEAGREEMENT (Filed With SEC on November 7, 2014)

Additional abbreviationsmay also be used though not in the above list. For Value Received, hereby sell, assign and transfer unto (Filed With SEC on November 7, 2014)

AMENDED AND RESTATED ROYALTY AGREEMENT (Filed With SEC on November 7, 2014)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on November 7, 2014)

HISTOGENICS CORPORATION SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS (Filed With SEC on October 7, 2014)

HISTOGENICS CORPORATION SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT TABLE OF CONTENTS (Filed With SEC on October 7, 2014)

WARRANT TO PURCHASESTOCK (Filed With SEC on October 7, 2014)

ROYALTY AGREEMENT (Filed With SEC on October 7, 2014)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 7, 2014)

INDEMNITY AGREEMENT (Filed With SEC on October 7, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on October 7, 2014)

Very truly yours, (Filed With SEC on October 7, 2014)

Exhibit A CONFIDENTIAL INFORMATION AND INTELLECTUAL PROPERTY ASSIGNMENT AGREEMENT (Filed With SEC on October 7, 2014)

HISTOGENICS CORPORATION 2012 EQUITY INCENTIVE PLAN (Filed With SEC on October 7, 2014)

HISTOGENICS CORPORATION 2013 EQUITY INCENTIVE PLAN (AS ADOPTED ON NOVEMBER 13, 2013) HISTOGENICS CORPORATION 2013 EQUITY INCENTIVE PLAN (Filed With SEC on October 7, 2014)

HISTOGENICS CORPORATION 2013 EMPLOYEE STOCK PURCHASE PLAN (AS ADOPTED ON NOVEMBER 13, 2013) HISTOGENICS CORPORATION 2013 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on October 7, 2014)

HISTOGENICS CORPORATION COMPENSATION PROGRAM FOR NON-EMPLOYEE DIRECTORS EFFECTIVE AS OF THE IPO DATE (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED AMENDMENT TO LICENSEAGREEMENT (1st Amendment) (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED SECOND AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED THIRD AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED FOURTH AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED FIFTH AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED REINSTATEMENT AGREEMENT AND SIXTH AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED SEVENTH AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED EIGHTH AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED Paid-up License Agreement (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED AGREEMENT (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on October 7, 2014)

FIRST AMENDMENT TO EXCLUSIVE AGREEMENT (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED SECOND AMENDMENT TO EXCLUSIVE AGREEMENT (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED AMENDMENT NO. 3 TO THE LICENSE AGREEMENT EFFECTIVE 04/15/2001 BETWEEN STANFORD UNIVERSITY AND HISTOGENICS CORPORATION (Filed With SEC on October 7, 2014)

AMENDMENT NO. 4 TO THELICENSE AGREEMENT EFFECTIVE 04/15/2001 BETWEEN STANFORD UNIVERSITY AND HISTOGENICS CORPORATION (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED LICENCE AGREEMENT Between YEDA RESEARCH ANDDEVELOPMENT COMPANY LIMITED (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED AMENDMENT TO LICENCE AGREEMENT Made and entered in to this 23rd day of March 2010 By and between YEDARESEARCH AND DEVELOPMENT COMPANY LIMITED (Filed With SEC on October 7, 2014)

LEASE AGREEMENT by and between INTERCONTINENTAL FUND III 830 WINTER STREET LLC, as Landlord and HISTOGENICS CORPORATION, asTenant With respect to the property known as 830 Winter... (Filed With SEC on October 7, 2014)

FIRST AMENDMENT TO LEASE (Filed With SEC on October 7, 2014)

HISTOGENICS CORPORATION 830 Winter Street Waltham, MA 02451 February 28, 2014 (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED COLLAGEN TECHNOLOGY TRANSFER AGREEMENT (Filed With SEC on October 7, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on October 7, 2014)

LEASE AGREEMENT (Filed With SEC on October 7, 2014)

LOAN AND SECURITY AGREEMENT (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on October 7, 2014)

Category

Industry

Companies

Contracts

HISTOGENICS CORP Contracts & Agreements